Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGM - Nasdaq Real Time Price USD

Cartesian Therapeutics, Inc. (RNAC)

Compare
10.67
+0.31
+(2.99%)
At close: 4:00:01 PM EDT
10.67
0.00
(0.00%)
After hours: 4:20:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
38,913
38,913
26,004
110,777
85,077
Operating Expense
75,231
75,231
111,710
96,239
89,674
Operating Income
-36,318
-36,318
-85,706
14,538
-4,597
Net Non Operating Interest Income Expense
7,386
7,386
2,131
-3,031
-2,844
Other Income Expense
-48,205
-48,205
-155,135
23,263
-2,280
Pretax Income
-77,137
-77,137
-238,710
34,770
-9,721
Tax Provision
287
287
-19,000
-609
15,966
Net Income Common Stockholders
-77,424
-77,424
-257,260
35,379
-25,687
Average Dilution Earnings
-446
-446
--
--
--
Diluted NI Available to Com Stockholders
-77,870
-77,870
-257,260
35,379
-25,687
Basic EPS
-4.48
--
-49.76
7.20
-6.60
Diluted EPS
-4.49
--
-49.76
3.00
-6.60
Basic Average Shares
17,276.82
--
5,170.32
4,825.29
3,810.96
Diluted Average Shares
17,357.94
--
5,170.32
4,862.50
3,810.96
Total Operating Income as Reported
-43,897
-43,897
-86,416
14,538
-4,597
Total Expenses
75,231
75,231
111,710
96,239
89,674
Net Income from Continuing & Discontinued Operation
-77,424
-77,424
-219,710
35,379
-25,687
Normalized Income
-38,863.31
-38,863.31
-76,286.89
17,261.93
-24,011.65
Interest Income
7,386
7,386
4,964
--
--
Interest Expense
--
--
2,833
3,031
2,844
Net Interest Income
7,386
7,386
2,131
-3,031
-2,844
EBIT
-77,137
-77,137
-235,877
37,801
-6,877
EBITDA
-75,986
-75,986
-235,034
39,088
-5,625
Reconciled Depreciation
1,151
1,151
843
1,287
1,252
Net Income from Continuing Operation Net Minority Interest
-77,424
-77,424
-219,710
35,379
-25,687
Total Unusual Items Excluding Goodwill
-48,811
-48,811
-155,826
22,933
-2,295
Total Unusual Items
-48,811
-48,811
-155,826
22,933
-2,295
Normalized EBITDA
-27,175
-27,175
-79,208
16,155
-3,330
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-10,250.31
-10,250.31
-12,402.89
4,815.93
-619.65
12/31/2021 - 6/22/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TRML Tourmaline Bio, Inc.
13.10
+8.26%
 
MLTX MoonLake Immunotherapeutics
34.90
+2.74%
 
APGE Apogee Therapeutics, Inc.
31.80
+6.21%
 
IRON Disc Medicine, Inc.
38.73
+9.93%
 
SYRE Spyre Therapeutics, Inc.
12.22
+2.43%
 
KYTX Kyverna Therapeutics, Inc.
2.0600
+10.16%
 
RLYB Rallybio Corporation
0.2503
-0.12%
 
DYN Dyne Therapeutics, Inc.
7.04
+0.86%
 
CABA Cabaletta Bio, Inc.
1.2300
+12.84%
 
PRAX Praxis Precision Medicines, Inc.
29.74
+4.46%